A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

Clinical trial NCT07404202 · RECRUITING

Trial details

NCT number: NCT07404202
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Pan-tumor(NSCLC, GYN Cancers, BTC and UC)

Start date: 2026-03-06
Primary completion: 2026-12-31
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.